TY  - JOUR 
AU  - Salter, Donald M.
AU  - Griffin, Meredyth
AU  - Muir, Morwenna
AU  - Teo, Katy
AU  - Culley, Jayne
AU  - Smith, James R.
AU  - Gómez Cuadrado, Laura
AU  - Matchett, Kylie
AU  - Sims, Andrew H.
AU  - Hayward, Larry
AU  - Henderson, Neil C.
AU  - Brunton, Valerie G.
PY  - 2019
SN  - 1754-8403
UR  - http://hdl.handle.net/10259/9798
AB  - Angiosarcomas are a rare group of tumours which have poor prognosis and limited treatment options. The development of new therapies has been hampered by a lack of good preclinical models. Here, we describe the development of an autochthonous mouse...
LA  - eng
PB  - The Company of Biologists
KW  - Angiosarcoma
KW  - TRP53
KW  - Genetically engineered mouse model
KW  - Lymphomas
KW  - Tumour
KW  - Oncología
KW  - Oncology
KW  - Salud
KW  - Health
KW  - Medicina
KW  - Medicine
TI  - Development of mouse models of angiosarcoma driven by p53
DO  - 10.1242/dmm.038612
T2  - Disease Models & Mechanisms
VL  - 12
ER  -